Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland

被引:0
作者
Marika Salminen
Marikka Kuoppamäki
Tero Vahlberg
Ismo Räihä
Kerttu Irjala
Sirkka-Liisa Kivelä
机构
[1] University of Turku,Institute of Clinical Medicine, Family Medicine
[2] Härkätie Health Centre,Unit of Family Medicine
[3] Turku University Hospital,Institute of Clinical Medicine, Biostatistics
[4] Naantali Health Centre,Department of Internal Medicine
[5] University of Turku,undefined
[6] Turku City Hospital,undefined
[7] Mehiläinen,undefined
[8] Satakunta Central Hospital,undefined
来源
Acta Diabetologica | 2011年 / 48卷
关键词
Metabolic syndrome; Vascular risk; Population-based study; Elderly; Aged;
D O I
暂无
中图分类号
学科分类号
摘要
The aim was to analyze the relationship between metabolic syndrome (MetS) and vascular risk among the aged. A prospective population-based study, with a 9-year follow-up. All subjects of the municipality of Lieto in Finland aged ≥64 in 1998–99 participated (n = 1183). Hazard ratios (HRs) for fatal or non-fatal coronary (CHD), cerebrovascular (CV), or all vascular events predicted by MetS (defined by International Diabetes Federation) were estimated. During the 9-year follow-up, a total of 348 vascular events occurred, including 208 CHD and 150 CV events. After multivariable adjustment, CHD events (1.70, 1.07–2.71, P = .026) and vascular events (1.57, 1.07–2.30, P = .021) were more common in men with MetS compared to men without it. Evaluating MetS components individually, low HDL-cholesterol among women predicted a higher occurrence of CV (2.44, 1.46–4.09, P < .001) and all vascular (1.78, 1.26–2.53, P = .001) events. Elevated blood pressure among men was related to fewer CHD events (0.46, 0.25–0.83, P = .010). Our findings suggest that MetS does predict vascular events in late life among men. In older women, only low HDL-cholesterol was associated with vascular risk. Slightly or moderately elevated blood pressure values do not predict vascular events in this age group.
引用
收藏
页码:157 / 165
页数:8
相关论文
共 167 条
[81]  
Ferrannini E(undefined)undefined undefined undefined undefined-undefined
[82]  
Stern M(undefined)undefined undefined undefined undefined-undefined
[83]  
Merz NB(undefined)undefined undefined undefined undefined-undefined
[84]  
Bonow RO(undefined)undefined undefined undefined undefined-undefined
[85]  
Sopko G(undefined)undefined undefined undefined undefined-undefined
[86]  
Wang J(undefined)undefined undefined undefined undefined-undefined
[87]  
Ruotsalainen S(undefined)undefined undefined undefined undefined-undefined
[88]  
Moilanen L(undefined)undefined undefined undefined undefined-undefined
[89]  
Lepistö P(undefined)undefined undefined undefined undefined-undefined
[90]  
Laakso M(undefined)undefined undefined undefined undefined-undefined